PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UTMD vs. DHR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UTMD and DHR is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

UTMD vs. DHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). The values are adjusted to include any dividend payments, if applicable.

-20.00%-15.00%-10.00%-5.00%0.00%5.00%SeptemberOctoberNovemberDecember2025February
-8.27%
-19.89%
UTMD
DHR

Key characteristics

Sharpe Ratio

UTMD:

-1.05

DHR:

-0.50

Sortino Ratio

UTMD:

-1.51

DHR:

-0.55

Omega Ratio

UTMD:

0.82

DHR:

0.93

Calmar Ratio

UTMD:

-0.45

DHR:

-0.45

Martin Ratio

UTMD:

-1.75

DHR:

-1.32

Ulcer Index

UTMD:

12.68%

DHR:

9.01%

Daily Std Dev

UTMD:

21.11%

DHR:

23.94%

Max Drawdown

UTMD:

-48.84%

DHR:

-65.35%

Current Drawdown

UTMD:

-48.79%

DHR:

-26.02%

Fundamentals

Market Cap

UTMD:

$200.04M

DHR:

$154.61B

EPS

UTMD:

$3.96

DHR:

$5.31

PE Ratio

UTMD:

15.15

DHR:

40.49

PEG Ratio

UTMD:

0.00

DHR:

4.03

Total Revenue (TTM)

UTMD:

$31.75M

DHR:

$23.88B

Gross Profit (TTM)

UTMD:

$18.31M

DHR:

$14.21B

EBITDA (TTM)

UTMD:

$13.00M

DHR:

$6.75B

Returns By Period

In the year-to-date period, UTMD achieves a -2.42% return, which is significantly higher than DHR's -6.33% return. Over the past 10 years, UTMD has underperformed DHR with an annualized return of 2.02%, while DHR has yielded a comparatively higher 20.08% annualized return.


UTMD

YTD

-2.42%

1M

-2.23%

6M

-8.27%

1Y

-17.65%

5Y*

-6.51%

10Y*

2.02%

DHR

YTD

-6.33%

1M

-8.44%

6M

-19.89%

1Y

-12.16%

5Y*

8.61%

10Y*

20.08%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UTMD vs. DHR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTMD
The Risk-Adjusted Performance Rank of UTMD is 77
Overall Rank
The Sharpe Ratio Rank of UTMD is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of UTMD is 55
Sortino Ratio Rank
The Omega Ratio Rank of UTMD is 77
Omega Ratio Rank
The Calmar Ratio Rank of UTMD is 1919
Calmar Ratio Rank
The Martin Ratio Rank of UTMD is 22
Martin Ratio Rank

DHR
The Risk-Adjusted Performance Rank of DHR is 1818
Overall Rank
The Sharpe Ratio Rank of DHR is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of DHR is 1919
Sortino Ratio Rank
The Omega Ratio Rank of DHR is 1919
Omega Ratio Rank
The Calmar Ratio Rank of DHR is 1919
Calmar Ratio Rank
The Martin Ratio Rank of DHR is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UTMD vs. DHR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for UTMD, currently valued at -1.05, compared to the broader market-2.000.002.004.00-1.05-0.50
The chart of Sortino ratio for UTMD, currently valued at -1.51, compared to the broader market-4.00-2.000.002.004.00-1.51-0.55
The chart of Omega ratio for UTMD, currently valued at 0.82, compared to the broader market0.501.001.502.000.820.93
The chart of Calmar ratio for UTMD, currently valued at -0.45, compared to the broader market0.002.004.006.00-0.45-0.45
The chart of Martin ratio for UTMD, currently valued at -1.75, compared to the broader market-10.000.0010.0020.0030.00-1.75-1.32
UTMD
DHR

The current UTMD Sharpe Ratio is -1.05, which is lower than the DHR Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of UTMD and DHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50SeptemberOctoberNovemberDecember2025February
-1.05
-0.50
UTMD
DHR

Dividends

UTMD vs. DHR - Dividend Comparison

UTMD's dividend yield for the trailing twelve months is around 2.01%, more than DHR's 0.50% yield.


TTM20242023202220212020201920182017201620152014
UTMD
Utah Medical Products, Inc.
2.01%1.96%1.41%1.16%2.86%1.33%1.02%1.31%1.31%1.44%1.75%1.67%
DHR
Danaher Corporation
0.50%0.47%0.43%0.38%0.26%0.32%0.44%0.62%0.60%36.46%0.80%0.47%

Drawdowns

UTMD vs. DHR - Drawdown Comparison

The maximum UTMD drawdown since its inception was -48.84%, smaller than the maximum DHR drawdown of -65.35%. Use the drawdown chart below to compare losses from any high point for UTMD and DHR. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-48.79%
-26.02%
UTMD
DHR

Volatility

UTMD vs. DHR - Volatility Comparison

The current volatility for Utah Medical Products, Inc. (UTMD) is 5.49%, while Danaher Corporation (DHR) has a volatility of 12.44%. This indicates that UTMD experiences smaller price fluctuations and is considered to be less risky than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%SeptemberOctoberNovemberDecember2025February
5.49%
12.44%
UTMD
DHR

Financials

UTMD vs. DHR - Financials Comparison

This section allows you to compare key financial metrics between Utah Medical Products, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab